• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

AI's Trial by Fire: Experimental Validation in Drug Discovery

Tuesday, June 04, 2024
Breakout Session
AI and Digital Health
24BC
AI is a transformative force in drug discovery. It now faces a "trial by fire"as it confronts the complexities of real-world medical challenges. Only rigorous experimental validation will bridge the gap between AI's predictions and its real-world applications. An active feedback loop between silico and experimental data is crucial to ensure we verify the integrity of AI findings, train algorithms, and adapt to and optimize for safe and effective clinical outcomes. Attendees will walk away from this session with the complexities that must be considered when working with AI and its breakthrough innovations.
Moderator
Nitya Sridhar
Senior Forecasting Associate
Amgen
Speakers
Martin Akerman, PhD
Co-founder and CTO
Envisagenics
Alex Zhavoronkov, PhD
CEO
Insilico
Michael Bembem, PhD
Director, Data Science and External Innovation
Johnson & Johnson
Etai Jacob, PhD
Senior Director, Head of Data Science and AI, Early Oncology
AstraZeneca
Stacie Calad Thomson, PhD
Chief Strategy Officer & Head of Drug Discovery
BioSymetrics
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS